Thioridazine as an Anticancer Therapeutic: Interplay with the Isoprenoid Biosynthetic Pathway
J. S. Weissenrieder, J. L. Reed, J. D. Neighbors, R. J. Hohl
This study investigates thioridazine's potential as an anticancer agent, finding its cytotoxic effects may relate to lipid metabolism disruption but with minimal biological significance.
bioRxiv · Jan 29, 2019 · PreprintPharmacology & Toxicology